Emerging trends and research foci of epithelial-mesenchymal transition in gliomas: A scientometric analysis and review

Deciphering the past status and future tendency: a comprehensive scientometric study on developmental dysplasia of the hip

BACKGROUND

Developmental dysplasia of the hip is a common musculoskeletal disorder in newborns and young children, attracting considerable controversy. The purpose of the present study was to analyze the research trends and hotspots over the past three decades in this field.

METHODS

All related publications were collected from the Web of Science Core Collection from 1994 to 2023. Of these, characteristics of the top 50 cited articles for each decade (1994-2003, 2004-2013 and 2014-2023) were evaluated in detail. Visualized studies were operated via VOSviewer. GraphPad Prism and Microsoft Excel were used to perform statistical analysis. The characteristic of the present study is a cross-sectional study.

RESULTS

In total, 1,300 publications with 19,815 citations from 1994 to 2023 were selected. The number of publications increased significantly during the past three decades, from 23 in 1994 to 132 in 2023 (P < 0.0001). Studies with collaboration among institutions have raised significantly over time (P < 0.0001). The United States was the leading country to the top 50 publications in each decade. Publications with evidence level IV led the way every ten years. Visualized co-occurrence analysis clustered the keywords into four clusters: hip arthroplasty, congenital dislocation, ultrasound diagnosis and developmental dysplasia of the hip.

CONCLUSIONS

This study analyzed the global tendency and collaborations on developmental dysplasia of the hip over the past three decades. Even though the research trend has evolved to be collaborative with more multi-institutional publications and authors, studies with high evidence levels are still missing.

A scientometric analysis of immunotherapies for gliomas: Focus on GBM

Gliomas are the most prevalent primary malignant brain tumors worldwide, with glioblastoma (GBM) being the most common and aggressive type. The standard therapy for GBM has remained unchanged for nearly two decades, with no significant improvement in survival outcomes. Despite several barriers such as the tumor microenvironment (TME) and blood-brain barrier, immunotherapies bring new hope for the treatment of GBM. To better understand the development and progress of immunotherapies in GBM, we made this scientometric analysis of this field. A total of 3753 documents were obtained from the Web of Science Core Collection, with publication years ranging from 1999 to 2022. The Web of Science platform, CiteSpace, and VOS viewer were used to conduct the scientometric analysis. The results of scientometric analysis showed that this field has recently become a popular topic of interest. The United States had the most publications among 89 countries or regions. Keyword analysis indicated significant areas in the field of immunotherapies for GBM, especially TME, immune checkpoint blockades (ICBs), chimeric antigen receptor T (CAR-T) cells, vaccines, and oncolytic viruses (OVs). Overall, we hope that this scientometric analysis can provide insights for researchers and promote the development of this field.

Advancements and current trends in tumor treating fields: a scientometric analysis

Tumor treating fields (TTFields) therapy is a novel and effective noninvasive cancer therapy, and it has been approved by FDA in the treatment of recurrent and newly diagnosed glioblastoma, and malignant pleural mesothelioma. Moreover, TTFields therapy has been widely studied in both clinical trials and preclinical studies in recent years. Based on its high efficacy, research on TTFields therapy has been a hot topic. Thus, the authors made this scientometric analysis of TTfields to reveal the scientometric distributions such as annual publications and citations, countries and institutions, authors, journals, references, and more importantly, research status and hot topics of the field. In recent years, publication numbers have been stable at high values, and citation numbers have been increasing greatly. The United States and Israel were the top two countries with the highest publication numbers, followed by Germany and Switzerland. Scientometric analyses of keywords indicated that clinical applications and antitumor mechanisms are probably the two main parts of current research on TTfields. Most clinical trials of TTfields focus on the treatment of glioblastoma. And a variety of other cancers such as lung cancer especially nonsmall cell lung cancer, hepatic cancer, other brain tumors, etc. have also been studied in both clinical trials and preclinical studies.

Trends in Global Research for Treating Intracranial Aneurysms: A Bibliometric Analysis

OBJECTIVE

Although significant advancements have been made in the detection, surveillance, and treatment of intracranial aneurysms, research and care can differ vastly based on location. Currently, there is lack of knowledge regarding the trends in literature and how the field is evolving with new technology. Here, we use bibliometric analysis to visualize the knowledge structure of the field and identify global research trends in intracranial aneurysm treatment.

METHODS

The Web of Science Core Collection was queried for primary research and review articles related to intracranial aneurysm treatment. Four thousand seven hundred and 2 relevant documents were collected and publications over time on different treatment types and publications and citations of journals were collected. VOS viewer was used for the following: 1) identify relationships between keywords, 2) identify co-authorship patterns among organizations and countries, and 3) analyze citation patterns of countries, organizations, and journals.

RESULTS

Our results show that research in flow diversion increased at a rapid rate but tended to have low link strength with keywords related to evaluating patient risk and mortality. The highest publication producing countries were the United States of America, Japan, and China, although China had fewer citations relative to its peers. Korean organizations showed less international collaboration. The USA has been the leader in terms of productivity and collaboration in the field, as have several US-based journals such as Journal of Neurosurgery, Neurosurgery, and World Neurosurgery.

CONCLUSIONS

Evaluating the safety of flow diversion treatment remains a pressing area of research. Chinese and Korean organizations may be of interest for global collaborations.

Danggui Shaoyaosan attenuates doxorubicin induced Nephrotic Syndrome through regulating on PI3K/Akt Pathway

The study aimed to explore the role and the underlying mechanism of Danggui Shaoyaosan (DSS) in nephrotic syndrome (NS). NS rat model was induced by doxorubicin injection twice. After DSS treatment, inflammation and oxidative stress index were detected via ELISA. Western blot was used for the protein detection. Go and KEGG analysis was applied to evaluate target gene and signaling of DSS. MCP-5 cell was applied for the cell rescue experiments and mechanism exploration. The 24 h urine protein levels of NS rats increased significantly, which was reduced by DSS treatment in a concentration-dependent manner. After DSS treatment, levels of BUN, SCr, TG and TC were also decreased, and serum ALB and TP levels were increased in rats. GO and KEGG pathway enrichment identified PI3K-Akt to be the candidate signaling of DSS in the treatment of NS, which was activated in NS rats. The recuse experiments in MCP-5 demonstrated that IGF-1, the agonist of PI3K/AKT, abolished the beneficial role of DSS in podocyte cell viability, apoptosis, inflammation and oxidative stress. In conclusion, DSS exerts a protective role against the development of NS. The mechanism is related to the improvement of podocyte injury and the inhibition of PI3K/Akt pathway-related proteins.

Immunotherapy in cervical cancer: From the view of scientometric analysis and clinical trials

BACKGROUND

Cervical cancer is the fourth most cancer and the fourth leading cause of cancer-related deaths in women worldwide. Current treatment for patients with advanced cervical cancer is limited. And in the urgent demand for novel effective therapies both as the first and the second line treatment for these patients, immunotherapy is developing fast and has made some achievements.

METHODS

This study incorporated 1,255 topic-related articles and reviews from 1999 to 2022 in the Web of Science Core Collection (WoSCC). The WoS platform, Citespace, and VOS viewer provided the annual distribution of publications and citations, the analysis of researching countries and institutions, references, keywords (co-occurrence analysis, burst analysis, and timeline view analysis), and researching authors, respectively. For clinical trials, 720 trials and 114 trials from ClinicalTrials.gov and ICTRP were retrieved, respectively. And 296 trials were finally incorporated into the analysis.

RESULTS

The scientometric analysis showed that the study of immunotherapies in cervical cancer developed fast in recent years. Most publications were from the United States, followed by China. Seven of the top 10 co-cited references belong to clinical trials, and five of them were published in recent five years. There are lots of clinical trials us specific treatment patterns, some of which have represented excellent effects.

CONCLUSIONS

Both the scientometric analysis of the 1,255 publications and the analysis of clinical trials showed that the field of immunotherapies in cervical cancer developed so fast in recent years. It was found that a lot of clinical trials using various immunotherapies (mainly vaccine therapy, adoptive cell therapy, immune checkpoint blockade, and antibody-drug conjugate) for advanced cervical cancer are currently ongoing or have represented considerable effect. Centered in immunotherapies, immune checkpoint blockades have represented great efficacy and huge potential, especially combined with other therapies such as chemotherapy, targeted therapy, and other immunotherapies.